← Back to all trials
Recruiting
NCT06244212
Topical Treatment for Atopic Dermatitis
Conditions: Atopic Dermatitis
Sex: All
Ages: 9 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Wake Forest University Health Sciences
Location: Wake Forest University Health Sciences Winston-Salem North Carolina
Summary
Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of skin dermatitis
* Age \> 9
* Ability to return for a one-week clinical studies follow-up
* Patients who are candidates for treatment with 0.1% triamcinolone ointment (even if they weren't in the study)
* Adult or pediatric patients with active dermatitis who receive dermatologic care at Atrium Health Wake Forest Baptist, Department of Dermatology.
Exclusion Criteria:
* Patients without the diagnosis of skin dermatitis
* Inability to return for a one week follow up appointment
* Body Surface Area (BSA) affected \
Source: ClinicalTrials.gov (NCT06244212). StuddyBuddy aggregates publicly available trial information.